Contact: Kerri Kelley; Last date for abstract submission: Not available; Discuss risk assessment & control strategies, HCP characterization, assay coverage, critical reagents & platforming, questions relating to HCPs in gene therapies, in-process testing & the latest data supporting the link between HCPs & immunogenicity.